Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Patient-Centered Acupuncture for Pain (PCAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02152020
Recruitment Status : Completed
First Posted : June 2, 2014
Last Update Posted : January 14, 2015
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania

Brief Summary:
The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites. Participants will be enrolled in either the Conventional Pain Management group or Integrative Pain Management group.

Condition or disease Intervention/treatment
Cancer Survivors Behavioral: Survey

Layout table for study information
Study Type : Observational
Estimated Enrollment : 36 participants
Time Perspective: Prospective
Official Title: Patient-Centered Integration of Acupuncture to Decrease Pain for Cancer Survivors
Study Start Date : May 2014
Actual Primary Completion Date : January 2015
Actual Study Completion Date : January 2015

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Cancer survivors Behavioral: Survey



Primary Outcome Measures :
  1. Number of Adverse Events [ Time Frame: 12 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Cancer survivors 18 years or older with pain ratings of 4 or greater on a 0-10 numerical rating scale; primary diagnosis of cancer (stages I-III); finished primary cancer treatment; Karnofsky score 60 or greater; and who have been taking pain medications daily.
Criteria

Inclusion Criteria:

  • Women or men age 18 years or older
  • Primary diagnosis of cancer with history of stage I, II, or III cancer
  • Finished primary cancer treatments (surgery, chemotherapy, radiotherapy)
  • Have a Karnofsky score of 60 or greater
  • Can understand written English
  • Have worst pain rated at least 4 or greater on an 11-point (0-10) numerical rating scale in the preceding week
  • Have been taking pain medications daily
  • Have had at least 15 days with pain in the preceding 30 days.

Exclusion Criteria:

  • Women or men with metastatic (stage IV) cancer
  • Unstable and progressive medical conditions as judged by the PIs or designated research nurse at the community hospitals (e.g., progressive cancer, uncontrolled heart failure) that may require hospitalization in the next 12 weeks
  • Planned surgical procedures in the next 12 weeks
  • Patients currently in a pain crisis as judged by the PI or designated research nurse that may warrant acute titration of medications or hospitalization
  • Women who are pregnant or breastfeeding
  • Unwillingness to adhere to study related procedures.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02152020


Locations
Layout table for location information
United States, Pennsylvania
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
Abramson Cancer Center of the University of Pennsylvania
Investigators
Layout table for investigator information
Principal Investigator: Jun Mao, MD Abramson Cancer Center of the University of Pennsylvania

Layout table for additonal information
Responsible Party: Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier: NCT02152020    
Other Study ID Numbers: UPCC 01914
First Posted: June 2, 2014    Key Record Dates
Last Update Posted: January 14, 2015
Last Verified: January 2015